2,5-dihydroxybenzoic acid has been researched along with Diabetic Angiopathies in 1 studies
2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Exner, M | 1 |
| Hermann, M | 1 |
| Hofbauer, R | 1 |
| Kapiotis, S | 1 |
| Speiser, W | 1 |
| Held, I | 1 |
| Seelos, C | 1 |
| Gmeiner, BM | 1 |
1 other study available for 2,5-dihydroxybenzoic acid and Diabetic Angiopathies
| Article | Year |
|---|---|
The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.
Topics: Arteriosclerosis; Aspirin; Cells, Cultured; Diabetic Angiopathies; Endothelium, Vascular; Gentisates | 2000 |